Andrew Hutchings

About Andrew Hutchings

Andrew is Co-Head of our Global M&A practice.

Andrew focuses on complex public and private cross-border M&A transactions. He regularly advises on transactions in the financial institutions sector and has previously co-headed our global Financial Institutions Group. He has also advised in a wide range of other sectors.  He regularly acts for listed companies, international groups and financial investors, including infrastructure funds.

In addition to M&A, Andrew has significant experience in governance and shareholder arrangements, group reorganisations and in relation to shareholder activism.

Andrew until recently led the transactions practice in London for a number of years. He is a regular 30% club mentor.

Recent work

• Advising London Stock Exchange Group on its:  
  • $27bn all share acquisition of Refinitiv and related sale of Borsa Italiana
  • defence of an unsolicited £32bn approach from HKSE
  • £21bn proposed merger with Deutsche Börse
  • acquisition of a majority stake in the LCH Group and related governance arrangements
  • acquisition of Frank Russell Company (and related rights issue) and the subsequent sale of Russell Investments.
• Advising AstraZeneca on the unsolicited takeover approach from Pfizer in respect of a proposed $118bn share for share acquisition.
• Advising Hellman & Friedman on its £4bn acquisition of the payments business, Nets.
• Advising on the sale of a minority interest in Terminal Investments to GIP and the subsequent investment by GIC, including related shareholder arrangements.
• Advising the partners of TT International (TTI), on the sale of the TTI business to the Japanese banking group, Sumitomo Mitsui Financial Group, Inc.
• Advising Patrizia on its auction acquisition of Rockspring, a UK asset manager.